{"id":"NCT00444964","sponsor":"Children's Mercy Hospital Kansas City","briefTitle":"Growth Hormone Use in Adults With Prader-Willi Syndrome","officialTitle":"Growth Hormone Use in Adults With Prader-Willi Syndrome","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2005-04","primaryCompletion":"2012-01-01","completion":"2012-01-01","firstPosted":"2007-03-08","resultsPosted":"2021-01-08","lastUpdate":"2021-01-08"},"enrollment":11,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"DIAGNOSTIC"},"conditions":["Prader-Willi Syndrome"],"interventions":[{"type":"DRUG","name":"Nutropin AQ","otherNames":["Growth Hormone"]}],"arms":[{"label":"Primary Cohort","type":"EXPERIMENTAL"}],"summary":"The main research question this protocol aims to answer is whether treatment with growth hormone will impact body composition, quality of life, and energy balance in PWS adults, and if there is a loss of effects after cessation of treatment for at least 12 months.","primaryOutcome":{"measure":"Body Composition","timeFrame":"12 and 24 months","effectByArm":[{"arm":"Primary Cohort","deltaMin":51.2,"sd":2.1}],"pValues":[{"comp":"OG000","p":"<0.05"}]},"eligibility":{"minAge":"16 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":8},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":11},"commonTop":[]}}